Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Apr;51(4):573–576. doi: 10.1038/bjc.1985.80

Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.

R Stuart-Harris, D W Hedley, I W Taylor, A L Levene, I E Smith
PMCID: PMC1977139  PMID: 3884030

Full text

PDF
573

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkin N. B. Modal deoxyribonucleic acid value and survival in carcinoma of the breast. Br Med J. 1972 Jan 29;1(5795):271–272. doi: 10.1136/bmj.1.5795.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Auer G., Eriksson E., Azavedo E., Caspersson T., Wallgren A. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res. 1984 Jan;44(1):394–396. [PubMed] [Google Scholar]
  3. Barlogie B., Raber M. N., Schumann J., Johnson T. S., Drewinko B., Swartzendruber D. E., Göhde W., Andreeff M., Freireich E. J. Flow cytometry in clinical cancer research. Cancer Res. 1983 Sep;43(9):3982–3997. [PubMed] [Google Scholar]
  4. Bichel P., Poulsen H. S., Andersen J. Estrogen receptor content and ploidy of human mammary carcinoma. Cancer. 1982 Nov 1;50(9):1771–1774. doi: 10.1002/1097-0142(19821101)50:9<1771::aid-cncr2820500921>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  5. Friedlander M. L., Hedley D. W., Taylor I. W. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol. 1984 Sep;37(9):961–974. doi: 10.1136/jcp.37.9.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Friedlander M. L., Taylor I. W., Russell P., Tattersall M. H. Cellular DNA content--a stable feature in epithelial ovarian cancer. Br J Cancer. 1984 Feb;49(2):173–179. doi: 10.1038/bjc.1984.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harris A. L., Powles T. J., Smith I. E. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer. Cancer Res. 1982 Aug;42(8 Suppl):3405s–3408s. [PubMed] [Google Scholar]
  8. Hayward J. L., Carbone P. P., Heusen J. C., Kumaoka S., Segaloff A., Rubens R. D. Assessment of response to therapy in advanced breast cancer. Br J Cancer. 1977 Mar;35(3):292–298. doi: 10.1038/bjc.1977.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983 Nov;31(11):1333–1335. doi: 10.1177/31.11.6619538. [DOI] [PubMed] [Google Scholar]
  10. Hedley D. W., Rugg C. A., Ng A. B., Taylor I. W. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. Cancer Res. 1984 Nov;44(11):5395–5398. [PubMed] [Google Scholar]
  11. Kute T. E., Muss H. B., Anderson D., Crumb K., Miller B., Burns D., Dube L. A. Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer. Cancer Res. 1981 Sep;41(9 Pt 1):3524–3529. [PubMed] [Google Scholar]
  12. Olszewski W., Darzynkiewicz Z., Rosen P. P., Schwartz M. K., Melamed M. R. Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer. 1981 Aug 15;48(4):980–984. doi: 10.1002/1097-0142(19810815)48:4<980::aid-cncr2820480421>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  13. Raber M. N., Barlogie B., Latreille J., Bedrossian C., Fritsche H., Blumenschein G. Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry. 1982 Jul;3(1):36–41. doi: 10.1002/cyto.990030109. [DOI] [PubMed] [Google Scholar]
  14. Smith I. E., Harris A. L., Morgan M., Gazet J. C., McKinna J. A. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma. Cancer Res. 1982 Aug;42(8 Suppl):3430s–3433s. [PubMed] [Google Scholar]
  15. Smith I. E., Harris A. L., Stuart-Harris R., Ford H. T., Gazet J. C., White H., Harmer C. L., Carr L., McKinna J. A., Morgan M. Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer. Br Med J (Clin Res Ed) 1983 May 21;286(6378):1615–1616. doi: 10.1136/bmj.286.6378.1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Taylor I. W., Musgrove E. A., Friedlander M. L., Foo M. S., Hedley D. W. The influence of age on the DNA ploidy levels of breast tumours. Eur J Cancer Clin Oncol. 1983 May;19(5):623–628. doi: 10.1016/0277-5379(83)90178-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES